Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$OSTX Q2 '26 Earnings Results & Recap

OS Therapies reported a net loss of $19.0 million for the six months ended June 30, 2026, with research and development expenses totaling $13.4 million during the same period.
2

Price since post

Full Details

Advertisement|Remove ads.